CVR: 44427923
DKK -17,345
Gross profit
Net result: DKK -13,529
Anders Ohlhues Baandrup, Dunnock Holding ApS
CVR · view ownership and management
Director registered: Carsten Højer
CVR · 09/11/2023
View the full event history
Spectoceutics ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Carsten Højer. The company is owned by Anders Ohlhues Baandrup and Dunnock Holding ApS. In 2025, the company reported a gross profit of DKK -17,345 and a net result of DKK -13,529. Equity in the 2025 report amounted to DKK 19,423.
Selskabets formål er at udvikle, markedsføre, licensere og sælge ny teknologi samt dermed beslægtede aktiviteter
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationSpectoceutics ApS was founded on 9 November 2023.
Spectoceutics ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
Spectoceutics ApS is owned by Anders Ohlhues Baandrup and Dunnock Holding ApS.
In 2025, Spectoceutics ApS reported a gross profit of DKK -17,345.
The management of Spectoceutics ApS consists of Carsten Højer.
Spectoceutics ApS is located at Solbakkevej 37A, 2820 Gentofte.
Claim this page to add your logo and social links. Free to get started.
Spectoceutics ApS has published its annual report for 2025. Gross profit came to DKK -17,345, and the net result was DKK -13,529.
Spectoceutics ApS has published its interim report for the period November 9, 2023 – December 31, 2024.
As of November 9, 2023, Carsten Højer is registered as director of Spectoceutics ApS.
As of November 9, 2023, Anders Ohlhues Baandrup is registered as an owner of Spectoceutics ApS with an ownership share of 5%.
As of November 9, 2023, Dunnock Holding ApS is registered as an owner of Spectoceutics ApS with an ownership share of 90%.
Spectoceutics ApS was founded on November 9, 2023.
Companies in the same industry and area
CVR 46551184
CVR 37109886
CVR 15994142
CVR 35190961
CVR 46290003
